journal
Journals Clinical Immunology : the Offi...

Clinical Immunology : the Official Journal of the Clinical Immunology Society

https://read.qxmd.com/read/37611838/antiretrovirals-to-ccr5-crispr-cas9-gene-editing-a-paradigm-shift-chasing-an-hiv-cure
#41
REVIEW
Amber Khan, Nandagopal Paneerselvam, Brian R Lawson
The evolution of drug-resistant viral strains and anatomical and cellular reservoirs of HIV pose significant clinical challenges to antiretroviral therapy. CCR5 is a coreceptor critical for HIV host cell fusion, and a homozygous 32-bp gene deletion (∆32) leads to its loss of function. Interestingly, an allogeneic HSCT from an HIV-negative ∆32 donor to an HIV-1-infected recipient demonstrated a curative approach by rendering the recipient's blood cells resistant to viral entry. Ex vivo gene editing tools, such as CRISPR/Cas9, hold tremendous promise in generating allogeneic HSC grafts that can potentially replace allogeneic ∆32 HSCTs...
August 21, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37604356/distinct-nod2-mutations-reported-in-three-families-with-blau-syndrome-bs-from-a-single-center-in-india-case-series-and-review-of-literature
#42
JOURNAL ARTICLE
Ritasman Baisya, Ramesh Manthri, Mudit Tyagi, Shantveer G Uppin, Liza Rajasekhar
OBJECTIVE: Blau syndrome (BS), considered a rare pediatric autoinflammatory disease, is characterised by a triad of granulomatous arthritis, dermatitis and uveitis. Here we present a tale of three families visited in our outpatient department in the last two years (2020-2022) where more than one member was affected with either skin, ophthalmological and joint involvement with either biopsy-proven granuloma or genetic mutation at NOD2 gene suggesting the diagnosis of BS. CASE SERIES: The first family had three affected members where the mother and her two children had skin changes, polyarthritis and a pathogenic mutation in NOD2 gene (exon 4, c...
August 19, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37604355/e3-ubiquitin-ligase-stub1-affects-the-mtorc1-pathway-through-p62-and-participates-in-regulating-the-differentiation-of-follicular-helper-t-cells-in-rheumatoid-arthritis
#43
JOURNAL ARTICLE
Wen Wang, Yachen Yang, Yujia Shi, Ting Xiang, Jianmin Xie
OBJECTIVE: The abnormal expansion of Tfh cells plays a key role in chronic inflammation of RA joint. We speculated that STUB1 is an important regulatory factor in promoting the differentiation of Tfh cells in RA. CONTENT AND METHODS: The proportion of Tfh cells and the level of STUB1 in Tfh cells was measured. CD4+ T cells were isolated from PBMCs of RA patients, and the percentage of Tfh cells was detected after up- or down-regulating the expression of STUB1. The levels of mTORC1 pathway activator p-mTOR and p-S6K were measured by Western blot...
August 19, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37604354/nk-cells-vs-obesity-a-tale-of-dysfunction-redemption
#44
REVIEW
Conor De Barra, Donal O'Shea, Andrew E Hogan
Natural killer (NK) cells are critical in protecting the body against infection and cancer. NK cells can rapidly respond to these threats by directly targeting the infected or transformed cell using their cytotoxic machinery or by initiating and amplifying the immune response via their production of cytokines. Additionally, NK cells are resident across many tissues including adipose, were their role extends from host protection to tissue homeostasis. Adipose resident NK cells can control macrophage polarization via cytokine production, whilst also regulating stressed adipocyte fate using their cytotoxic machinery...
August 19, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37595937/metagenome-wide-association-study-of-gut-microbiome-features-for-myositis
#45
JOURNAL ARTICLE
Yimin Li, Jun Xu, Yixiang Hong, Zijun Li, Xiaoyan Xing, Yunzhi Zhufeng, Dan Lu, Xu Liu, Jing He, Yuhui Li, Xiaolin Sun
PURPOSE: The clinical relevance and pathogenic role of gut microbiome in both myositis and its associated interstitial lung disease (ILD) are still unclear. The purpose of this study was to investigate the role of gut microbiome in myositis through comprehensive metagenomic-wide association studies (MWAS). METHODS: We conducted MWAS of the myositis gut microbiome in a Chinese cohort by using whole-genome shotgun sequencing of high depth, including 30 myositis patients and 31 healthy controls (HC)...
August 16, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37595936/cross-disease-characterization-of-fibroblast-heterogeneities-and-their-pathogenic-roles-in-skin-inflammation
#46
JOURNAL ARTICLE
Zhiguo Li, Tianyu Cao, Qingyang Li, Jingliang Zhang, Jing Du, Jiaoling Chen, Yaxing Bai, Junfeng Hao, Zhanlai Zhu, Hongjiang Qiao, Meng Fu, Erle Dang, Gang Wang, Shuai Shao
Fibroblasts are critical pro-inflammatory regulators in chronic inflammatory and fibrotic skin diseases. However, fibroblast heterogeneity and the absence of a unified cross-disease taxonomy have hindered our understanding of the shared/distinct pathways in non-communicable skin inflammation. By integrating 10× single-cell data from 75 skin samples, we constructed a single-cell atlas across inflammatory and fibrotic skin diseases and identified 9 distinct subsets of skin fibroblasts. We found a shared subset of CCL19+ fibroblasts across these diseases, potentially attracting and educating immune cells...
August 16, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37586673/clinical-correlates-of-a-subset-of-anti-fibroblast-antibodies-in-systemic-sclerosis
#47
JOURNAL ARTICLE
Elvira Favoino, Paola Cipriani, Vasiliki Liakouli, Addolorata Corrado, Luca Navarini, Marta Vomero, Adriana Sisto, Rosa Daniela Grembiale, Francesco Ciccia, Francesco P Cantatore, Piero Ruscitti, Roberto Giacomelli, Federico Perosa
Anti-fibroblast antibodies (AFA) have been reported in systemic sclerosis (SSc) and are known to promote fibroblast activation. Aim of this study was to characterize the fine specificity of AFA and to analyze any correlations with clinical parameters associated to fibrosis. To this end, AFA were affinity-purified from a patient with diffuse cutaneous SSc (dcSSc) and interstitial lung disease (ILD). Panning of a phage display peptide library with purified AFA identified the motif <KxywxQ>. The peptide p121, bearing the AFA-specific motif, was used in ELISA to screen sera from 186 SSc patients and 81 healthy donors...
August 14, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37586672/clinical-characteristics-and-immune-profiles-of-patients-with-immune-mediated-alopecia-associated-with-covid-19-vaccinations
#48
JOURNAL ARTICLE
Chuang-Wei Wang, Ming-Ying Wu, Chun-Bing Chen, Wei-Chen Lin, Jennifer Wu, Chun-Wei Lu, Wei-Ti Chen, Fang-Ying Wang, Rosaline Chung-Yee Hui, Min-Hui Chi, Tsu-Man Chiu, Ya-Ching Chang, Jing Yi Lin, Yang Yu-Wei Lin, Wan-Ting Tsai, Shuen-Iu Hung, Wen-Hung Chung
BACKGROUND: The clinical characteristics and pathomechanism for immune-mediated alopecia following COVID-19 vaccinations are not clearly characterized. OBJECTIVE: We investigated the causality and immune mechanism of COVID-19 vaccines-related alopecia areata (AA). STUDY DESIGN: 27 new-onset of AA patients after COVID-19 vaccinations and 106 vaccines-tolerant individuals were enrolled from multiple medical centers for analysis. RESULTS: The antinuclear antibody, total IgE, granulysin, and PARC/CCL18 as well as peripheral eosinophil count were significantly elevated in the patients with COVID-19 vaccines-related AA compared with those in the tolerant individuals (P = 2...
August 14, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37586671/non-invasive-diagnosis-of-primary-sj%C3%A3-gren-s-syndrome-using-ultrasonography-and-transcriptome-biomarkers
#49
JOURNAL ARTICLE
Shihao Xu, Chengwei Zhu, Jiachun Jiang, Cheng Hui, Ping Wang, Jingwei Hong, Shiping Yang, Zhongshan Li, Xiaobing Wang
Diagnosing primary Sjögren's syndrome (pSS) is difficult due to clinical heterogeneity and the absence of non-invasive specific biomarkers. To develop non-invasive pSS diagnosis methods that integrate classic clinical indexes, major salivary gland ultrasonography (SGUS), and gene expression profiles shared by labial gland and peripheral blood, we conducted a study on a cohort of 358 subjects. We identified differentially expressed genes (DEGs) in glands and blood that were enriched in defense response to virus and type I interferon production pathways...
August 14, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37573228/corrigendum-to-the-clinical-and-immunological-characteristics-in-fetal-severe-fever-with-thrombocytopenia-syndrome-virus-sftsv-infection-clinical-immunology-2023-109262
#50
Ming Huang, Ting Wang, Yi Huang, Yun Wang, Shiji Wu, Feng Wang, Guoxing Tang, Wei Wei, Weiyong Liu, Hongyan Hou
No abstract text is available yet for this article.
August 10, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37572951/the-immune-imbalance-between-follicular-regulatory-and-helper-t-cells-in-myelin-oligodendrocyte-glycoprotein-igg-associated-disease
#51
JOURNAL ARTICLE
Xuechun Chang, Kexin Jiao, Danjie Wang, Yufan Zhou, Zhao Zhao, Ying Xing, Jingzi Zhangbao, Chuanzhen Lu, Jun Wang, Chao Quan
BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a newly defined inflammatory demyelinating disease of the central nervous system. Currently, no immuno-modulatory treatment has been approved for MOGAD. METHODS: We explored the function of follicular regularoty T (Tfr) and follicular helper T (Tfh) cells in patients with MOGAD. The number of circulating Tfr and Tfh cells and their expression of functional markers were accessed by flow cytometry...
August 10, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37572950/antiphospholipid-syndrome-nephropathy-current-knowledge-and-unanswered-questions
#52
JOURNAL ARTICLE
Eleni Xourgia, Maria G Tektonidou
The definition of acute and chronic antiphospholipid syndrome (APS) nephropathy was recently updated using a multiphase methodology in the context of the development of the new APS classification criteria. Currently, there is no consensus for the treatment of APS nephropathy, which mainly relies on the general recommendations for the management of APS. Based on evidence from experimental studies and a few clinical studies and case series, targeted treatments such as B-cell depletion, anti-B-cell activating factor antibody, complement inhibition, mammalian target of rapamycin inhibition, and neutrophil extracellular traps or interferon targeting may show promise for the treatment of microvascular manifestations in APS, including APS nephropathy...
August 10, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37572949/high-epstein-barr-virus-capsid-antigen-igg-level-associates-with-the-carriership-of-cd8-t-cell-somatic-mutations-in-the-stat3-sh2-domain
#53
JOURNAL ARTICLE
Joonas Lehikoinen, Miko Valori, Anne J Jääskeläinen, Sini M Laakso, T Petteri Arstila, Pentti J Tienari
High carrier prevalence of STAT3 SH2 domain somatic mutations was recently discovered in CD8+ T cells. We found these low-allele-fraction clones in 26% of donors, without difference between multiple sclerosis (MS) patients and controls. Here we tested whether anti-viral antibodies associate with the carriership of these mutant clones. We compared antibody responses against common viruses in mutation carriers vs. non-carriers. Plasma samples of 152 donors (92 MS patients, 60 controls) were analyzed for antibodies against cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus-6A and parvovirus B19...
August 10, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37567492/nlrc4-gain-of-function-variant-is-identified-in-a-patient-with-systemic-lupus-erythematosus
#54
JOURNAL ARTICLE
Qintao Wang, Xiaohua Ye, Wenjie Zheng, Taijie Jin, Yan Zhou, Xiaoya Hu, Qing Zhou, Xiaomin Yu
NLRC4 gain-of-function variants are known to cause various autoinflammatory phenotypes, including familial cold autoinflammatory syndrome (FCAS4) and NLRC4 macrophage activation syndrome (NLRC4-MAS). However, to date, no study has linked NLRC4 gain-of-function variants to systemic lupus erythematosus (SLE). In this study, we identified a novel NLRC4 W655S variant in an SLE patient and her son, who had neonatal lupus complicated with macrophage activation syndrome. Our in vitro experiments demonstrated that the W655S NLRC4 increased ASC speck formation and mature IL-1β secretion compared to the wild-type NLRC4...
August 10, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37562721/subcutaneous-panniculitis-like-t-cell-lymphoma-in-two-unrelated-individuals-with-benta-disease
#55
JOURNAL ARTICLE
Bradly M Bauman, Batsukh Dorjbal, Stefania Pittaluga, Yu Zhang, Julie E Niemela, Jennifer L Stoddard, Sergio D Rosenzweig, Ronald Anderson, Gregory M T Guilcher, Iwona Auer, Renee Perrier, Martin Campbell, Samarjeet K Bhandal, Camille Alba, Gauthaman Sukumar, Clifton L Dalgard, Magdalena Schelotto, Nicola A M Wright, Helen C Su, Andrew L Snow
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous non-Hodgkin lymphoma involving CD8+ T cells, the genetic underpinnings of which remain incompletely understood. Here we report two unrelated patients with B cell Expansion with NF-κB and T cell Anergy (BENTA) disease and a novel presentation of SPTCL. Patient 1 presented early in life with recurrent infections and B cell lymphocytosis, linked to a novel gain-of-function (GOF) CARD11 mutation (p.Lys238del). He developed SPTCL-like lesions and membranoproliferative glomerulonephritis by age 2, treated successfully with cyclosporine...
August 9, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37562724/modulation-of-bone-marrow-and-peripheral-blood-cytokine-levels-by-age-and-clonal-hematopoiesis-in-healthy-individuals
#56
JOURNAL ARTICLE
Noémie Ravalet, Hélène Guermouche, Pierre Hirsch, Frédéric Picou, Amélie Foucault, Nathalie Gallay, Jean-Alain Martignoles, Jenny Beaud, Ludovic Suner, Caroline Deswarte, Sébastien Lachot, Emmanuelle Rault, Laëtitia Largeaud, Valérie Gissot, Marie-Christine Béné, Emmanuel Gyan, François Delhommeau, Olivier Herault
Aging is associated with bone marrow (BM) inflammaging and, in some individuals, with the onset of clonal hematopoiesis (CH) of indeterminate potential. In this study conducted on 94 strictly healthy volunteers (18 to 80 yo), we measured BM and peripheral blood (PB) plasma levels of 49 hematopoietic and inflammatory cytokines. With aging, 7 cytokines increased in BM (FLT3L, CXCL9, HGF, FGF-2, CCL27, IL-16, IL-18) and 8 decreased (G-CSF, TNF, IL-2, IL-15, IL-17A, CCL7, IL-4, IL-10). In PB, 10 cytokines increased with age (CXCL9, FLT3L, CCL27, CXCL10, HGF, CCL11, IL-16, IL-6, IL-1 beta, CCL2)...
August 8, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37562723/elevated-glucose-metabolism-driving-pro-inflammatory-response-in-b-cells-contributes-to-the-progression-of-type-1-diabetes
#57
JOURNAL ARTICLE
Zeying Li, Mingjiu Zhao, Jingyue Li, Wenjun Luo, Juan Huang, Gan Huang, Zhiguo Xie, Yang Xiao, Jiaqi Huang, Xia Li, Bin Zhao, Zhiguang Zhou
Type 1 diabetes (T1D) is an autoimmune disease characterized by the immune system's failure to maintain self-tolerance, resulting in the autoimmune destruction of pancreatic beta cells. Although T1D has conventionally been viewed as a T-cell-dominant disease, recent research has emphasized the contribution of B cells in the onset of the disease. However, the mechanism underlying aberrant B cell responses remains unknown. B cell metabolism is a crucial prerequisite for B cell function and the development of adaptive immune responses...
August 8, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37562722/age-dependent-transcriptomic-profiles-of-leukocytes-in-pediatric-population
#58
JOURNAL ARTICLE
Sophia Koutsogiannaki, Samuel Kim, Koichi Yuki
Immunity at birth is considered immature. Following birth, our immune function is considered to grow and reach maturation over time. To obtain granular information of leukocyte functions and transcriptomic profiles in pediatric cohort, we examined leukocyte profiles in infants, preschool and school children using single cell RNA sequencing of their peripheral blood mononuclear cells (PBMCs). Monocytes and natural killer (NK) cells showed immaturity in infants. Their innate and adaptive immunity was developed by preschool age...
August 8, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37558149/assessing-disease-activity-and-damage-in-antiphospholipid-syndrome
#59
JOURNAL ARTICLE
Danieli Andrade, Maria G Tektonidou
Antiphospholipid syndrome (APS) has been characterized by a variety of vascular and pregnancy manifestations related to an interplay between thrombotic and inflammatory mechanisms, a progressive accrual of irreversible organ damage and increased morbidity and mortality rates, supporting a high need of optimal treatment approach. The lack of standardized outcome measures is a significant barrier in the design of clinical studies in APS. Disease activity (in principle reversible) and its distinction from disease damage (in principle irreversible) needs to be evaluated by validated scores for use in clinical trials but also in daily clinical practice in APS...
August 8, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37544491/umbilical-cord-blood-and-peripheral-blood-derived-regulatory-t-cells-therapy-progress-in-type-1-diabetes
#60
REVIEW
Yuanjie Bi, Ran Kong, Yani Peng, Haibo Yu, Zhiguang Zhou
Regulatory T cells (Tregs) are key regulators for the inflammatory response and play a role in maintaining the immune tolerance. Type 1 diabetes (T1D) is a relatively common autoimmune disease that results from the loss of immune tolerance to β-cell-associated antigens. Preclinical models have demonstrated the safety and efficacy of Tregs given in transplant rejection and autoimmune diseases such as T1D. Adoptive transfer of Tregs has been utilized in clinical trials for over a decade. However, the achievement of the adoptive transfer of Tregs therapy in clinical application remains challenging...
August 4, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
journal
journal
34593
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.